The U.S. Dollar Gained Considerable Strength In 2015

Jan 13, 2016

By USDA

The value of the U.S. dollar against other major currencies strengthened considerably in 2015, accelerating a trend that began in 2011. The agricultural trade-weighted exchange rate is a broad measure of the value of the dollar against 79 foreign currencies, weighted by their share of U.S. agricultural exports.

The dollar exchange rate affects the price of U.S. commodities in foreign markets, with a stronger dollar making U.S. products more expensive in terms of the local currency of importing countries. On the other hand, a stronger dollar makes U.S. imports less expensive in dollar terms. Since the dollar exchange rate affects the relative price of U.S. and foreign commodities in global markets, it can have important implications for agricultural trade.

With the strengthening of the dollar in 2015, agricultural exports are expected to fall below 2014 levels, while imports are forecast to increase. ERS exchange rate projections used for the USDA Agricultural Projections to 2025 report (the current Agricultural Baseline) suggest the dollar will continue to gain strength—but at a slower pace—in 2016 and 2017, before trending lower from 2018 through 2025.

The dollar gained considerable strength in 2015

Source:usda.gov

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.